ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY

Objective: To evaluate the success rate of injection ‘methotrexate’ in the management of ectopic pregnancy. Study Design: A single group interventional study. Place and Duration of Study: NESCOM Hospital Islamabad, from Jan 2014 to Dec 2017. Methodology: All patients admitted with ectopic p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mussarat Sultana, Saima Perveen, Sadia Kashif, Huma Karamat, Fasih Hashmi
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2020
Materias:
R
Acceso en línea:https://doaj.org/article/73ecb0b30da3419eafc6aa9904db0d04
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:73ecb0b30da3419eafc6aa9904db0d04
record_format dspace
spelling oai:doaj.org-article:73ecb0b30da3419eafc6aa9904db0d042021-12-02T17:18:25ZROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY0030-96482411-8842https://doaj.org/article/73ecb0b30da3419eafc6aa9904db0d042020-10-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/5554https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To evaluate the success rate of injection ‘methotrexate’ in the management of ectopic pregnancy. Study Design: A single group interventional study. Place and Duration of Study: NESCOM Hospital Islamabad, from Jan 2014 to Dec 2017. Methodology: All patients admitted with ectopic pregnancy fulfilling the inclusion criteria i.e, a stable clinical condition, no evidence of rupture on ultrasound, normal liver and renal functions were included in the study, while the patients who were showing signs of rupture ectopic or with abnormal liver and renal functions were excluded from the study. Data was collected on predesigned performa. Diagnostic tools were Transvaginal Sonography and serial serum β-human chorionic gonadotropin levels .These patients were treated with injection methotrexate 50 mg/kg body weight. Serum β-human chorionic gonadotropin levels were done on day 4 and day 7 and weekly thereafter till ≤5 mIU/ml. Results: The total number of patients (88) with 18-39 years, fulfilling the inclusion criteria were given injection methotrexate. Medical treatment was successful in 81.8% of patients whereas failure was observed in 18.2%. Among which 67 patients were given single dose, 20 patients received 2 doses and only 01 patient needed 3 doses. The mean resolution time for β-human chorionic gonadotropin level was 21 days (11-58). Average resolution time for adnexal masses (<3cm) was 19 days and for adnexal masses (>3cm) was 39 days. Conclusion: Methotrexate was found to be safe, cost effective and fertility preserving alternative to the surgical management of ectopic pregnancy.Mussarat SultanaSaima PerveenSadia KashifHuma KaramatFasih HashmiArmy Medical College Rawalpindiarticleectopic pregnancymethotrexateβhcg levelMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 70, Iss 5, Pp 1305-1309 (2020)
institution DOAJ
collection DOAJ
language EN
topic ectopic pregnancy
methotrexate
βhcg level
Medicine
R
Medicine (General)
R5-920
spellingShingle ectopic pregnancy
methotrexate
βhcg level
Medicine
R
Medicine (General)
R5-920
Mussarat Sultana
Saima Perveen
Sadia Kashif
Huma Karamat
Fasih Hashmi
ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY
description Objective: To evaluate the success rate of injection ‘methotrexate’ in the management of ectopic pregnancy. Study Design: A single group interventional study. Place and Duration of Study: NESCOM Hospital Islamabad, from Jan 2014 to Dec 2017. Methodology: All patients admitted with ectopic pregnancy fulfilling the inclusion criteria i.e, a stable clinical condition, no evidence of rupture on ultrasound, normal liver and renal functions were included in the study, while the patients who were showing signs of rupture ectopic or with abnormal liver and renal functions were excluded from the study. Data was collected on predesigned performa. Diagnostic tools were Transvaginal Sonography and serial serum β-human chorionic gonadotropin levels .These patients were treated with injection methotrexate 50 mg/kg body weight. Serum β-human chorionic gonadotropin levels were done on day 4 and day 7 and weekly thereafter till ≤5 mIU/ml. Results: The total number of patients (88) with 18-39 years, fulfilling the inclusion criteria were given injection methotrexate. Medical treatment was successful in 81.8% of patients whereas failure was observed in 18.2%. Among which 67 patients were given single dose, 20 patients received 2 doses and only 01 patient needed 3 doses. The mean resolution time for β-human chorionic gonadotropin level was 21 days (11-58). Average resolution time for adnexal masses (<3cm) was 19 days and for adnexal masses (>3cm) was 39 days. Conclusion: Methotrexate was found to be safe, cost effective and fertility preserving alternative to the surgical management of ectopic pregnancy.
format article
author Mussarat Sultana
Saima Perveen
Sadia Kashif
Huma Karamat
Fasih Hashmi
author_facet Mussarat Sultana
Saima Perveen
Sadia Kashif
Huma Karamat
Fasih Hashmi
author_sort Mussarat Sultana
title ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY
title_short ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY
title_full ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY
title_fullStr ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY
title_full_unstemmed ROLE OF INJECTION METHOTREXATE IN THE MANAGEMENT OF ECTOPIC PREGNANCY
title_sort role of injection methotrexate in the management of ectopic pregnancy
publisher Army Medical College Rawalpindi
publishDate 2020
url https://doaj.org/article/73ecb0b30da3419eafc6aa9904db0d04
work_keys_str_mv AT mussaratsultana roleofinjectionmethotrexateinthemanagementofectopicpregnancy
AT saimaperveen roleofinjectionmethotrexateinthemanagementofectopicpregnancy
AT sadiakashif roleofinjectionmethotrexateinthemanagementofectopicpregnancy
AT humakaramat roleofinjectionmethotrexateinthemanagementofectopicpregnancy
AT fasihhashmi roleofinjectionmethotrexateinthemanagementofectopicpregnancy
_version_ 1718381093110939648